ARDENT PHARMACEUTICALS
DEAD

Serial Number

76232405

Owner

ARDENT PHARMACEUTICALS, INC.

Attorney

JOHN C. LINDSEY

Filing Date

Mar 29, 2001

Add to watchlist:

No watchlists yet
View on USPTO

ARDENT PHARMACEUTICALS Trademark

Serial Number: 76232405

ARDENT PHARMACEUTICALS is a trademark filed by ARDENT PHARMACEUTICALS, INC. on March 29, 2001. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

ARDENT PHARMACEUTICALS, INC. (2 trademarks)

631 UNITED DRIVE
DURHAM, NC 27713

Entity Type: 03

Delta Pharmaceuticals, Inc. (2 trademarks)

631 United Drive, Suite 200
Durham, NC 27731

Entity Type: 03

Trademark Details

Filing Date

March 29, 2001

Registration Date

Not Registered

Published for Opposition

April 23, 2002

Goods & Services

pharmaceutical preparations, namely pharmaceuticals for use in the treatment of urinary incontinence, heart diseases, narcotic overdose and addiction, immune system diseases, neurological conditions, and depression and; analgesics; glaucoma agents

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
May 9, 2005 MAB6
ABANDONMENT - NO USE STATEMENT FILED
May 9, 2005 ABN6
SOU EXTENSION 4 GRANTED
Aug 6, 2004 EX4G
CASE FILE IN TICRS
Jul 19, 2004 CFIT
SOU EXTENSION 4 FILED
Jul 9, 2004 EXT4
SOU TEAS EXTENSION RECEIVED
Jul 9, 2004 EEXT
SOU EXTENSION 3 GRANTED
Jan 13, 2004 EX3G
SOU EXTENSION 3 FILED
Jan 13, 2004 EXT3
SOU TEAS EXTENSION RECEIVED
Jan 13, 2004 EEXT
SOU EXTENSION 2 GRANTED
Jul 18, 2003 EX2G
SOU EXTENSION 2 FILED
Jul 11, 2003 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 11, 2003 EEXT
SOU EXTENSION 1 GRANTED
Mar 18, 2003 EX1G
SOU EXTENSION 1 FILED
Jan 13, 2003 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 13, 2003 EEXT
NOA MAILED - SOU REQUIRED FROM APPLICANT
Jul 16, 2002 NOAM
PUBLISHED FOR OPPOSITION
Apr 23, 2002 PUBO
NOTICE OF PUBLICATION
Apr 3, 2002 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 16, 2001 CNSA
EXAMINER'S AMENDMENT MAILED
Jun 29, 2001 CNEA
ASSIGNED TO EXAMINER
Jun 29, 2001 DOCK
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 23, 2001 CRFA